We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Real-Time PCR System Offers Integrated qPCR and Genotyping Applications

By LabMedica International staff writers
Posted on 05 May 2010
A new high productivity, real-time PCR system that integrates a variety of quantitative PCR (qPCR) and genotyping applications will be available in June 2010.

The new system, the Applied Biosystems ViiA Real-Time PCR, is a product of Life Sciences Corporation (Carlsbad, CA, USA), a global biotechnology tools company that describes itself as being "dedicated to improving the human condition”. More...


The ViiA Real-Time PCR System incorporates a software package that melds standard real-time PCR applications such as nucleic acid quantification, detection of single nucleotide polymorphisms (SNPs), and copy number variation detection with others that include high-resolution melting, protein analysis with proximity ligation technology, and gene expression analysis performed directly from cultured cells without RNA purification. All applications are integrated and easily accessible from a touch screen so that investigators can operate the system without a separate computer and monitor runs from remote locations.

"In the past decade, quantitative real-time PCR has become a cornerstone technology for the life science researcher, allowing scientists around the world to identify molecular markers for disease and precisely measure how changes in activity at the genome level translate to significant molecular outcomes in living systems,” said Peter Dansky, president of molecular biology systems for Life Technologies. "By integrating a broad portfolio of real-time PCR applications on a single high-performance platform, the ViiA 7 Real-Time PCR System will vastly increase the productivity of researchers and inspire them to develop novel workflows that lead to an even greater understanding of the molecular basis of health and disease.”

Related Links:

Life Sciences Corporation



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.